Compare COEP & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COEP | PHUN |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 55.9M |
| IPO Year | N/A | N/A |
| Metric | COEP | PHUN |
|---|---|---|
| Price | $15.85 | $2.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 71.0K | ★ 165.6K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $500,996.00 | ★ $2,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $1.83 |
| 52 Week High | $21.41 | $6.29 |
| Indicator | COEP | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 41.56 |
| Support Level | $15.40 | $1.83 |
| Resistance Level | $16.80 | $2.13 |
| Average True Range (ATR) | 1.57 | 0.12 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 20.64 | 61.54 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.